Figure 2From: A randomised phase 1 study to investigate safety, pharmacokinetics and impact on gut microbiota following single and multiple oral doses in healthy male subjects of SMT19969, a novel agent for Clostridium difficile infectionsMedian log10 CFU/mL changes in gut microbiota composition for all Group G subjects. Abbreviations: LFE = Lactose fermenting enterobacteriaceae.Back to article page